In this exclusive interview with TrakCel, one of our first Cell & Gene Therapy (CGT) partners, we explain how Manufacturing Execution Systems (MES) like Werum PAS-X MES by Körber are driving the advancement of CGT manufacturing. Discover how MES can help ensure scalability, compliance, and quality in the manufacturing process, as well as the challenges that arise in scaling up CGT production. Learn about the differences between traditional pharma and CGT manufacturing, and how MES can work as a key driver in improving CGT.
Dr. Judith Koliwer, Principal Consultant Cell & Gene Therapy at Körber: “There is a strong need for an integrated ecosystem solution covering the entire supply chain in the CGT sector, and this is a different network of providers than traditional pharma. Our approach, however, is the same; we look to build partnerships with the best-in-class solutions that work together with the MES to reduce the obstacles for our customers. Systems like the MES play a central role in the ecosystem and are often integrated with many of the other systems, so it is vital they support both current and future requirements.”